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Background: The current best treatment option for patients with end-stage heart failure is allograft heart transplantation, which is limited 
by donor source and immunorejection. Generating an autologous bioartificial heart could overcome these. Here we demonstrate perfusion 
decellularization of human whole heart generating a biocompatible construct that preserves three-dimensional architecture.
Methods: We used 23 human hearts rejected for transplantation. Nineteen were decellularized by coronary perfusion with sodium dodecylsulfate 
detergent for 4-5 to 7-8 days; and 4 were used as controls. Matrices were examined structurally (endoscopy, ultrasound, angiography, optical 
computed tomography), mechanically, histologically and immunologically. Biocompatibility of the decellularized matrix was assessed by in vitro 
culture of human mesenchymal bone-marrow-derived stem cells and H9c2 cells derived from rat heart myocardium on regions of decellularized left 
ventricle matrix for 7 days.
Results: Perfusion decellularization removed cells by day 4-5; 7-8 days offered no improvement. The decellularization process preserves the 
three-dimensional macrostructure, chamber geometry, valve competency, fiber orientation, composition of the extracellular matrix, and the native 
microvascular network of the heart in a perfusable state. The three-dimensional decellularized heart matrix reseeded with cells supported cell 
attachment, alignment and survival at 1, 2 and 7 days.
Conclusions: Decellularization of cadaveric whole human hearts is feasible and yields a biocompatible scaffold with intact three-dimensional 
architecture and preserved mechanical properties. These findings represent a first step toward manufacture of human perfusionable heart grafts or 
matrix components as an alternative source of tissues for cardiovascular disease and open the door for other complex human organ engineering.
